Wear Time Assessment

Wear time assessment measures transdermal patch durability and adhesion maintenance. Adhesion loss reduces patch retention necessitating replacement. Premature loss reduces dose delivery and efficacy. Extended wear enables reduced application frequency. In vitro testing predicts clinical wear performance.

Clinical assessment confirms wear time predictions. Replacement requirements guide dosing schedules. Regulatory submissions justify wear claims. Patient counselling addresses application and replacement. Post-approval monitoring identifies wear patterns.